title: The off-label conundrum.
abstract: Off-label use of biologics is increasing as treatment successes, patient demand, and new indications grow. While scientific evidence and medical opinion still guide usage, high costs, unknown side effects, and legal ramifications are primary concerns for payers, physicians, and manufacturers.
authors: Katherine T
authors: KT
authors: Adams